Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
Journal of Clinical Oncology - United States
doi 10.1200/jco.2009.23.6075
Full Text
Open PDFAbstract
Available in full text
Date
November 10, 2009
Authors
Publisher
American Society of Clinical Oncology (ASCO)